FDA advisers move a step closer on COVID-19 vaccines for kids under 5
CBSN
COVID-19 vaccine shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
The Food and Drug Administration's outside vaccine advisers gave a thumbs-up to Moderna's two shots for the littlest kids. The panel is set to vote later Wednesday on whether to also recommend Pfizer's three-shot series for the young age group.
The outside experts voted unanimously that the benefits of Moderna's shots outweigh any risks for children under 5 — a group that includes roughly 18 million youngsters.
More Related News